Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard M Breyer

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
Annals of Neurology|October 1, 2008
The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosisXibin Liang, Qian Wang, Ju Shi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 13, 2004
Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemiaLouise McCullough, Liejun Wu, Norman Haughey, et al.
Journal of Neurochemistry|November 9, 2002
Neuronal oxidative damage from activated innate immunity is EP2 receptor-dependentThomas J Montine, Dejan Milatovic, Ramesh C Gupta, et al.
Molecular Metabolism|June 6, 2017
Opposing effects of prostaglandin E<sub>2</sub> receptors EP3 and EP4 on mouse and human β-cell survival and proliferationBethany A Carboneau, Jack A Allan, Shannon E Townsend, et al.
Blood|November 24, 2011
Blockade of prostaglandin E2 signaling through EP1 and EP3 receptors attenuates Flt3L-dependent dendritic cell development from hematopoietic progenitor cellsPratibha Singh, Jonathan Hoggatt, Peirong Hu, et al.
Endocrinology|September 10, 2003
Disrupted function of tumor necrosis factor-alpha-stimulated gene 6 blocks cumulus cell-oocyte complex expansionScott A Ochsner, Anthony J Day, Marilyn S Rugg, et al.
Hypertension (Dallas, Tex. : 1979)|November 5, 2019
Central EP3 (E Prostanoid 3) Receptors Mediate Salt-Sensitive Hypertension and Immune ActivationLiang Xiao, Hana A Itani, Luciana Simao do Carmo, et al.
The Journal of Clinical Investigation|July 3, 2002
Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin IIZhonghua Qi, Chuan-Ming Hao, Robert I Langenbach, et al.
Plos One|June 29, 2016
Myeloid Cell Prostaglandin E2 Receptor EP4 Modulates Cytokine Production but Not Atherogenesis in a Mouse Model of Type 1 DiabetesSara N Vallerie, Farah Kramer, Shelley Barnhart, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|April 21, 2016
Knockout of the Prostaglandin E<sub>2</sub> Receptor Subtype 3 Promotes Eccentric Cardiac Hypertrophy and Fibrosis in MiceShuang Liu, Yawei Ji, Jian Yao, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Annals of Neurology|October 1, 2008
The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosisXibin Liang, Qian Wang, Ju Shi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 13, 2004
Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemiaLouise McCullough, Liejun Wu, Norman Haughey, et al.
Journal of Neurochemistry|November 9, 2002
Neuronal oxidative damage from activated innate immunity is EP2 receptor-dependentThomas J Montine, Dejan Milatovic, Ramesh C Gupta, et al.
Molecular Metabolism|June 6, 2017
Opposing effects of prostaglandin E<sub>2</sub> receptors EP3 and EP4 on mouse and human β-cell survival and proliferationBethany A Carboneau, Jack A Allan, Shannon E Townsend, et al.
Blood|November 24, 2011
Blockade of prostaglandin E2 signaling through EP1 and EP3 receptors attenuates Flt3L-dependent dendritic cell development from hematopoietic progenitor cellsPratibha Singh, Jonathan Hoggatt, Peirong Hu, et al.
Endocrinology|September 10, 2003
Disrupted function of tumor necrosis factor-alpha-stimulated gene 6 blocks cumulus cell-oocyte complex expansionScott A Ochsner, Anthony J Day, Marilyn S Rugg, et al.
Hypertension (Dallas, Tex. : 1979)|November 5, 2019
Central EP3 (E Prostanoid 3) Receptors Mediate Salt-Sensitive Hypertension and Immune ActivationLiang Xiao, Hana A Itani, Luciana Simao do Carmo, et al.
The Journal of Clinical Investigation|July 3, 2002
Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin IIZhonghua Qi, Chuan-Ming Hao, Robert I Langenbach, et al.
Plos One|June 29, 2016
Myeloid Cell Prostaglandin E2 Receptor EP4 Modulates Cytokine Production but Not Atherogenesis in a Mouse Model of Type 1 DiabetesSara N Vallerie, Farah Kramer, Shelley Barnhart, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|April 21, 2016
Knockout of the Prostaglandin E<sub>2</sub> Receptor Subtype 3 Promotes Eccentric Cardiac Hypertrophy and Fibrosis in MiceShuang Liu, Yawei Ji, Jian Yao, et al.
Pageof 9